Document quand l'auteur est "Bourgault, Steve"

Article

Haddad, Mohamed; Gaudreault, Roger; Sasseville, Gabriel; Nguyen, Phuong Trang; Wiebe, Hannah; Van De Ven, Theo; Bourgault, Steve; Mousseau, Normand et Ramassamy, Charles ORCID: https://orcid.org/0000-0002-3252-5878 (2022). Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity International Journal of Molecular Sciences , vol. 23 , nº 5:2643. pp. 1-24. DOI: 10.3390/ijms23052643.

Binette, Vincent; Côté, Sébastien; Haddad, Mohamed; Nguyen, Phuong Trang; Bélanger, Sébastien; Bourgault, Steve; Ramassamy, Charles ORCID: https://orcid.org/0000-0002-3252-5878; Gaudreault, Roger et Mousseau, Normand (2021). Corilagin and 1,3,6-Tri-O-galloy-beta-d-glucose: potential inhibitors of SARS-CoV-2 variants Physical Chemistry Chemical Physics , vol. 23 , nº 27. pp. 14873-14888. DOI: 10.1039/D1CP01790J.

Tchoumi Neree, Armelle; Nguyen, Phuong Trang; Chatenet, David; Fournier, Alain et Bourgault, Steve (2014). Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP FEBS Letters , vol. 588 , nº 24. pp. 4590-4596. DOI: 10.1016/j.febslet.2014.10.029.

Doan, Ngoc-Duc; Bourgault, Steve; Dejda, Agnieszka; Létourneau, Myriam; Detheux, Michel; Vaudry, David; Vaudry, Hubert; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2011). Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects Biochemical Pharmacology , vol. 81 , nº 4. pp. 552-561. DOI: 10.1016/j.bcp.2010.11.015.

Bourgault, Steve; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Wurtz, Olivier; Doan, Ngoc Duc; Leprince, Jérôme; Vaudry, Hubert; Fournier, Alain et Vaudry, David (2011). Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug Current Pharmaceutical Design , vol. 17 , nº 10. pp. 1002-1024. DOI: 10.2174/138161211795589337.

Chapitre de livre

Chatenet, David; Bourgault, Steve et Fournier, Alain (2015). Design and application of light-activated probes for cellular signaling In: Nuclear G-Protein Coupled Receptors. Methods in Molecular Biology, 1234 (1234). Springer, New York, pp. 17-30.

Document issu d'une conférence ou d'un atelier

Vaudry, David; Doan, Ngoc Duc; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Bourgault, Steve; Dejda, Agnieszka; Basille, Magali; Botia, Béatrice; Vaudry, Hubert et Fournier, Alain (2012). Characterization of the neurotrophic effects of PACAP and development of new analogs for therapeutic applications In: Summer Neuropeptide Conference / Meeting of the European-Neuropeptide-Club (ENC), May 22-25, 2011, Boston, MA.

Doan, Ngoc Duc; Bourgault, Steve; Létourneau, Myriam; Vaudry, David; Detheux, Michel; Vaudry, Hubert; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2012). How specific are the antagonists of PACAP receptors In: 10th International Symposium on VIP-PACAP and Related Peptides, December 13-16, 2011, Eilat, ISRAEL.

Dejda, Agnieszka; Seaborn, Tommy; Bourgault, Steve; Touzani, Omar; Fournier, Alain; Vaudry, Hubert et Vaudry, David (2012). PACAP and a novel stable analogue protect rat brain from ischemia through same mechanisms In: 10th International Symposium on VIP-PACAP and Related Peptides, December 13-16, 2011, Eilat, ISRAEL.

Guinard, O; Bourgault, Steve et Fournier, Alain . Identification et caractérisation de l'effet contractile intracellulaire de l'endothéline-1 humaine. In: 3e édition, Congrès INRS-Institut Armand Frappier 2003, 6-8 novembre 2003, Stoneham.

Thèse

Bourgault, Steve (2009). Développement d'agonistes stables du récepteur PAC1 : étude des relations structure-activité du Pituitary Adenylate Cyclase-Activating Polypeptide Thèse. Québec, Université du Québec, Institut National de la Recherche Scientifique, Doctorat en biologie, 178 p.

Bourgault, Steve (2004). Développement de peptides vasoactifs photoactivables. Mémoire. Québec, Université du Québec, Institut National de la Recherche Scientifique, Maîtrise en sciences expérimentales de la santé, 124 p.